Header Logo

Connection

Sunita Nathan to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Sunita Nathan has written about Alemtuzumab.
Sunita Nathan
Connection Strength
0.041
Alemtuzumab
  1. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2018 11 13; 2(21):2922-2936.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.